Parkinson’s Disease Basics

Introduction to Parkinson’s disease

Biochemical and Neuropathological Context

Certain pathological changes are found in the brains of people with Parkinson’s, including so-called Lewy bodies. These are abnormal inclusions found inside some neurons and contain aggregates of misfolded alpha-synuclein, along with other cellular components. Lewy pathology is a key neuropathological hallmark of Parkinson’s. The exact mechanisms by which alpha-synuclein aggregation contributes to neuronal dysfunction and cell loss, and how this relates to clinical symptoms, remain an active area of research.

Genetics & Parkinson’s

Parkinson’s can occur sporadically or run in families. Most cases are sporadic and likely arise from a combination of genetic susceptibility and environmental factors rather than a single clear genetic cause. In a smaller number of cases, specific genetic mutations can play a major role. Variants in genes such as SNCA, LRRK2, and PRKN are associated with increased risk and, in some families, inherited forms of Parkinson’s. Research into Parkinson’s genetics helps clarify disease mechanisms and may support the development of more targeted therapies in the future.

PD Motor Symptoms

The main motor symptoms of Parkinson’s include tremor (shaking), rigidity (muscle stiffness), bradykinesia (slowness of movement), and postural instability (loss of balance), which often becomes more prominent later in the disease. These symptoms are linked to degeneration of dopamine-producing neurons in the substantia nigra, leading to reduced dopamine levels in the striatum and disruption of basal ganglia circuits that normally help initiate and smooth movements. This imbalance contributes to the characteristic motor features of Parkinson’s.

Parkinson’s Non-Motor Symptoms

Non-motor symptoms are also common in Parkinson’s and can significantly affect daily life. These may include sleep disturbances (including REM sleep behaviour disorder), cognitive changes, depression and anxiety, fatigue, autonomic dysfunction (such as constipation, urinary problems, and orthostatic hypotension), and sensory changes (such as reduced sense of smell). Non-motor symptoms can appear years before motor symptoms in some people and require comprehensive assessment and management.

Global prevalence of Parkinson’s disease

Reported rates of Parkinson’s are often higher in high-income countries such as the USA, Germany, and Japan. This likely reflects older population structures, longer life expectancy, and better access to neurological care and diagnosis. In many low- and middle-income regions, lower reported rates may be influenced by underdiagnosis, limited healthcare access, shorter life expectancy, and gaps in health reporting. Global efforts should focus on improving data quality and access to care to better understand genetic, environmental, and social factors and to strengthen prevention, diagnosis, and treatment worldwide.

Symptoms

Before diagnosis: The premotor phase

Before motor symptoms become apparent and allow a diagnosis of Parkinson’s, patients may experience a number of non-motor symptoms that often go unnoticed or not directly associated with the later diagnosis. These may include:

• Loss of Smell (Anosmia): Often an early indicator.
• Sleep Disorders: Vivid dreams, restless sleep.
• Digestive Issues: Problems with the digestive system, especially chronic constipation.
• Mood Changes: Early signs of depression or anxiety.

The premotor period offers a potential window for early intervention, provided symptoms are correctly identified and associated with Parkinson’s.

At the onset of the disease: The early motor Phase

With the onset of motor symptoms, the diagnosis of Parkinson’s disease becomes more likely. The initial motor symptoms can be subtle and sometimes asymmetrical (one-sided). They may include:

• Tremor: A resting tremor, often described as a “pill-rolling tremor’’.
• Rigor: An unusual stiffness in an arm or leg.
• Bradykinesia: A slight slowing of movements or reduced facial expressions.
• Postural Changes: A slight change in posture or instability when standing.

Later stages: the advanced phase

In the later stages of Parkinson’s, symptoms become more intense and coping with everyday life becomes increasingly challenging:

• Limitation of movement: Difficulty in walking and standing.
• Cognitive Decline: Memory loss, dementia.
• Speech problems: The voice may become quiet and monotonous, and speech may be slurred.
• Dysphagia: Difficulty in swallowing can pose serious risks such as aspiration pneumonia.
• Motor fluctuations: Phases of good mobility (“on phases”) alternate with phases of limited mobility (“off phases”).

As symptoms progress, care and management of the disease becomes more complex and often requires a multidisciplinary approach to treat both the motor and non-motor aspects of the disease.

Overall, Parkinson’s disease goes through a multifaceted symptom development, ranging from subtle initial signs to severe motor and non-motor symptoms that significantly affect daily life. A deep understanding of these phases and personalized, phase-specific care are essential to optimize the quality of life of Parkinson’s patients and effectively manage their challenges.

Therapy

The treatment of Parkinson’s disease is multifaceted and often requires an individualized, multi-professional strategy to effectively address both the motor and non-motor symptoms of the disease. The most common therapies include:

Standard therapies

• Drug therapy: The gold standard in Parkinson’s therapy remains the administration of levodopa (L-DOPA), often in combination with a DOPA decarboxylase inhibitor such as carbidopa. Other medications may include dopamine agonists, MAO-B inhibitors or anticholinergics.
• Deep brain stimulation (DBS): For patients who no longer respond to medications and who suffer from motor fluctuations, deep brain stimulation (DBS) may be an option. It involves implanting electrodes in specific areas of the brain that control movement in order to alleviate motor symptoms.
• Physiotherapy: A key component in maintaining mobility and preventing falls using special exercises to train flexibility, strength and balance.

Sport and exercise as therapy

• Movement therapy: Dance, yoga or Tai Chi have proven particularly valuable for Parkinson’s patients by addressing both physical and psychological aspects.
• Occupational therapy: The focus here is on coping with everyday life. The therapist works with the patient to find solutions to remain independent despite motor limitations.
• Aquatherapy: Training in water reduces the risk of falls and enables fluid movements, which is particularly beneficial for stiff, rigid muscles.

Sport and exercise are not only essential for maintaining motor functions, but they also have a positive effect on emotional well-being and quality of life.

Overall, the effective treatment of Parkinson’s disease requires a holistic, multidimensional strategy that is tailored to the individual needs and symptoms of the patient.

Innovative and new approaches

• Gene therapy: This involves trying to slow or even stop the progression of the disease by introducing genetic material. Various approaches are currently in clinical trials.
• Stem cell therapy: The use of stem cells to regenerate dopamine-producing neurons is a promising approach, but it is still being researched.
• Transcranial magnetic stimulation (TMS): A non-invasive approach that uses magnetic fields to influence neuronal activity in the brain. TMS is currently being further researched for its effectiveness in Parkinson’s symptoms.
• Immunotherapy: A new approach aims to modulate the immune system to prevent or at least slow down the death of neurons.
• and many others

Most of innovative therapeutic approaches are still in the research stage and have not yet been established as standard therapy. However, they illustrate the diversity and innovative power of current research in the field of Parkinson’s therapy.

Overall, the effective treatment of Parkinson’s disease requires a holistic, multidimensional strategy that is tailored to the individual needs and symptoms of the patient.

Importance of data in research

Patient insights, knowledge and health data plays a vital role in advancing Parkinson’s research and treatment. Analyzing this data not only deepens understanding of the disease but also helps develop new therapies. When patients share their information, it can lead to personalized treatment strategies tailored to individual needs. Also, researchers can uncover patterns and trends that reveal insights into the causes and progression of Parkinson’s. This data also aids in selecting candidates for clinical trials, ensuring that studies are optimized for the right participants.

Find out why we are building the global Kill Parkinson Registry here with insights from the global Parkinson’s community.

Patients who donate their data contribute significantly to research. Everyday data from medical records, diaries, or wearable devices provides real-world evidence, helping scientists understand how Parkinson’s impacts daily life. Long-term data allows researchers to track the disease over years, offering valuable insights into its progression.

However, patient data must be handled with care. Anonymization is essential to protect identities, and patients must give informed consent before their data is used. Transparency about how the data will be utilized is crucial for maintaining trust.

With proper data protection and ethical practices in place, patient data becomes a powerful resource, accelerating research and fostering new, innovative therapies that bring hope to Parkinson’s patients worldwide.

Cure

There is currently no cure for Parkinson’s, but promising research is underway. Advances in stem cell therapy, gene therapy, dynamic deep brain stimulation and the utilization of alternative therapies such as vitamin B1, vitamin B3, Mucuna Pruriens, UDCA, N-Acetyl-DL-Leucine (ADLL) and many others.offer hope, though they raise ethical and safety concerns. Stem cells could replace damaged brain cells, but ethical debates about their source and long-term safety continue. Gene therapy may alter harmful genes, though its long-term effects remain uncertain. Deep brain stimulation, while effective, needs more study in younger patients.

Collecting and analyzing patient data is critical to understanding Parkinson’s causes, developing personalized treatments, and possibly predicting and preventing the disease. More patient data could accelerate breakthroughs, but ethical data use and patient privacy must be prioritized.

Further resources

Basic Websites

• Michael J. Fox Foundation (michaeljfox.org): Leading organization in Parkinson’s research, offering information on the disease, research, and study participation.
• German Society for Parkinson’s and Movement Disorders (parkinson-gesellschaft.de): Central scientific-medical association in Germany focused on Parkinson’s research.
• Parkinson’s UK (parkinsons.org.uk): The UK’s top charity for Parkinson’s, providing comprehensive support and information.
• France Parkinson (franceparkinson.fr): French organization dedicated to supporting Parkinson’s patients.

Sources of people with Parkinson’s, Forums, and Communities

• Now more than ever (jetzt-erst-recht.info): Podcast by Kathrin, sharing positive stories from people with Parkinson’s, relatives, and therapists (some episodes in English).
• PatientsLikeMe (patientslikeme.com): A community platform for exchanging experiences and networking with others affected by Parkinson’s.
• Parkinson’s Movement (parkinsonsmovement.com): A platform for learning about Parkinson’s research and therapy, with active discussions.
• Parkinson’s UK Forum (forum.parkinsons.org.uk): A forum for UK patients and caregivers.
• MyParkinsonsTeam (myparkinsonsteam.com): A social network for people living with Parkinson’s.

Scientific and Research-Oriented Pages

• PubMed (pubmed.ncbi.nlm.nih.gov): A database of scientific articles providing insights into Parkinson’s research.
• Journal of Parkinson’s Disease (journalofparkinsonsdisease.com): Access to current research and studies on Parkinson’s.
• Parkinson’s Disease and Movement Disorders Society (movementdisorders.org): Latest research and treatment developments.
• Google Scholar (scholar.google.com): Access to scientific publications on Parkinson’s for
• Parkinson’s News Today (parkinsonsnewstoday.com): News, articles, and blogs on the latest Parkinson’s research, therapy, and care.
• The Science of Parkinson’s (scienceofparkinsons.com): Blog explaining complex research on Parkinson’s in layperson-friendly language.